Osaic Holdings
LVTX

Osaic Holdings’s LAVA Therapeutics LVTX Stock Holding History

Osaic Holdings’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,110
Closed -$1.41K – 7824
2025
Q1 		$1.41K Buy
+1,110
New +$1.24K ﹤0.01% 6710
2023
Q4 		– Sell
-48
Closed -$71 – 7400
2023
Q3 		$71 Hold
48
– – ﹤0.01% 7255
2023
Q2 		$97 Hold
48
– – ﹤0.01% 7290
2023
Q1 		$80 Hold
48
– – ﹤0.01% 7350
2022
Q4 		$0 Hold
48
– – ﹤0.01% 7338
2022
Q3 		$0 Hold
48
– – ﹤0.01% 7412
2022
Q2 		$0 Hold
48
– – ﹤0.01% 7498
2022
Q1 		$0 Hold
48
– – ﹤0.01% 7390
2021
Q4 		$0 Hold
48
– – ﹤0.01% 7492
2021
Q3 		$0 Buy
+48
New +$345 ﹤0.01% 7257

Other funds holding LVTX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
PFA
Pathway Financial Advisors South Burlington, Vermont $857M AUM 17.21% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return